Sabby Management’s Redhill Biopharma RDHL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-53,648
| Closed | -$497K | – | 46 |
|
|
2024
Q2 | $497K | Sell |
53,648
-39,122
| -42% | -$363K | 0.33% | 3 |
|
|
2024
Q1 | $1.23M | Buy |
+92,770
| New | +$1.23M | 0.71% | 4 |
|
|
2023
Q4 | – | Sell |
-25,400
| Closed | -$324K | – | 72 |
|
|
2023
Q3 | $324K | Buy |
+25,400
| New | +$324K | 0.24% | 18 |
|
|
2023
Q1 | – | Sell |
-7,450
| Closed | -$1.05M | – | 105 |
|
|
2022
Q4 | $1.05M | Buy |
+7,450
| New | +$1.05M | 0.92% | 11 |
|
|
2021
Q3 | – | Sell |
-340
| Closed | -$2.34M | – | 120 |
|
|
2021
Q2 | $2.34M | Sell |
340
-291
| -46% | -$2M | 0.33% | 22 |
|
|
2021
Q1 | $4.62M | Buy |
+631
| New | +$4.62M | 0.9% | 7 |
|
|
2018
Q1 | – | Sell |
-21
| Closed | -$110K | – | 106 |
|
|
2017
Q4 | $110K | Buy |
+21
| New | +$110K | 0.01% | 63 |
|
|
2017
Q2 | – | Sell |
-108
| Closed | -$1.04M | – | 158 |
|
|
2017
Q1 | $1.04M | Sell |
108
-84
| -44% | -$806K | 0.06% | 42 |
|
|
2016
Q4 | $2.01M | Buy |
192
+128
| +200% | +$1.34M | 0.12% | 23 |
|
|
2016
Q3 | $888K | Sell |
64
-84
| -57% | -$1.17M | 0.03% | 78 |
|
|
2016
Q2 | $1.61M | Sell |
148
-9
| -6% | -$98K | 0.08% | 47 |
|
|
2016
Q1 | $1.92M | Sell |
157
-3
| -2% | -$36.6K | 0.1% | 47 |
|
|
2015
Q4 | $2.06M | Sell |
160
-14
| -8% | -$181K | 0.11% | 41 |
|
|
2015
Q3 | $2.24M | Buy |
+174
| New | +$2.24M | 0.09% | 57 |
|
|
2015
Q2 | – | Sell |
-108
| Closed | -$1.57M | – | 196 |
|
|
2015
Q1 | $1.57M | Buy |
+108
| New | +$1.57M | 0.07% | 62 |
|